Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: doe x 2 months major surgical or invasive procedure: cabg x 3 (lima->lad, svg->om, svg->diag), mvrepair (28mm band) history of present illness: 55 y/o with known cad, cypher stent to lcx , now with recurrent angina. past medical history: cad s/p lcx cypher stent h/o rheumatic fever htn lipids physical exam: nad hr 70, b/p 128/68 admission exam unremarkable. pertinent results: 06:10am blood hct-25.4* 06:05am blood wbc-5.6 rbc-3.48* hgb-7.9* hct-24.0* mcv-69* mch-22.7* mchc-32.9 rdw-18.3* plt ct-144* 06:05am blood plt ct-144* 05:16am blood pt-13.4* ptt-27.0 inr(pt)-1.2* 06:10am blood k-4.2 06:05am blood glucose-113* urean-13 creat-0.8 na-135 k-3.8 cl-99 hco3-30 angap-10 brief hospital course: he was taken to the operating room on where he underwent a cabg x 3 and mvrepair. he was transferred to the sicu in critical but stable condition. he was extubated later that same day. he was found to be in svt and started on an esmolol drip. his svt resolved and he was weaned from his vasoactive drips. he was transferred to the floor on pod #3. he continued to do well post operatively and was ready for discharge home on pod #5. medications on admission: toprol, quinapril, hctz, lipitor, plavix, tricor, asa discharge medications: 1. furosemide 20 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 5 days. disp:*10 tablet(s)* refills:*0* 2. potassium chloride 10 meq capsule, sustained release sig: two (2) capsule, sustained release po q12h (every 12 hours) for 5 days. disp:*20 capsule, sustained release(s)* refills:*0* 3. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*50 tablet(s)* refills:*0* 4. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 5. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 6. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 7. atorvastatin 40 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 8. quinapril 20 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 9. tricor 145 mg tablet sig: one (1) tablet po once a day. 10. toprol xl 50 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po once a day. disp:*30 tablet sustained release 24hr(s)* refills:*0* discharge disposition: home with service facility: discharge diagnosis: cad s/p lcx cypher stent h/o rheumatic fever htn lipids discharge condition: good. discharge instructions: call with fever, redness or drainage from incision or weight gain more than 2 pound sin one day or five in one week. shower, no baths, no lotions, creams or powders to incisions. no lifting more than 10 pounds in one day or five in one week. followup instructions: dr. 4 weeks dr. 2 weeks procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of two coronary arteries open heart valvuloplasty of mitral valve without replacement diagnoses: coronary atherosclerosis of native coronary artery mitral valve disorders unspecified essential hypertension other and unspecified angina pectoris 

Answer: The patient is high likely exposed to